Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Edscharp who wrote (9736)	4/29/1999 6:42:00 AM
From: Anaxagoras	Respond to of 17367

Missed an obvious point.... When (well, make that "if") the music stops for Internuts then the day traders will move to biotech for their doses of event driven announcements. We're still probably a ways off from that in a serious way, but it wouldn't surprise me if some (the ones who don't do this on a regular basis already) were starting to transition. The meningococcemia trial announcement is just the kind of thing that, in the right atmosphere, would fuel a spike, IMO. Instead there may just be a bump. We'll see. Anaxagoras